Minute Insight: Abbott Is Planning To Combine Glucose And Ketone Measurement Into One Wearable
The company announced that it is developing a new biowearable device that will continuously monitor both glucose and ketone levels with one sensor.
You may also be interested in...
Nutromics is working on a portfolio of aptamer-based sensors capable of measuring a wide range of analytes found in interstitial fluid.
In this month’s Digital Health roundup, Medtech Insight’s Marion Webb discusses her deep-dive article on menopause with leading experts in this rising industry and Barnaby Pickering highlights UK-based Proximie, which developed a web-based platform that allows surgeons and other clinical experts to collaborate virtually in the operating suite. The company recently raised $80m in a series C round.
Korean pharma firm poised to file for domestic approval of SGLT-2 inhibitor enavogliflozin after positive top-line Phase III data, marking progress for the country's first drug in the already crowded class. But will it be competitive?